Prevotella histicola Preparations for Autoimmune Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autoimmune conditions such as arthritis and multiple sclerosis are inadequate in reducing the severity of these diseases, as existing therapies often have limited efficacy and may cause significant side effects.
Innovation Solution
The use of Prevotella histicola preparations, including live or killed microorganisms and culture supernatants, administered orally as medicaments or dietary supplements, which modulate the immune system by reducing inflammatory responses and promoting anti-inflammatory cytokines, thereby treating autoimmune conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for autoimmune conditions are used, then disease severity reduction is limited, but side effects are significant
Solution Approach 1:
The patent introduces Prevotella histicola as a microbial intermediary that mediates between the host immune system and the autoimmune condition. This probiotic microorganism acts as a biological mediator to modulate immune responses, reducing disease severity without the harmful side effects associated with conventional pharmaceutical treatments. The P. histicola serves as a safe intermediary substance that promotes regulatory T cell development and anti-inflammatory cytokine production.
2Reliability
If Prevotella histicola preparations are administered, then disease severity is reduced by more than 25%, but the mechanism requires modulation of immune system through live or killed microorganisms
Solution Approach 1:
The patent applies parameter changes by offering multiple forms of P. histicola preparations with different viability states (live versus killed microorganisms) and different administration routes (oral medicaments, dietary supplements, culture supernatants). This allows optimization of treatment parameters based on specific patient needs while maintaining efficacy. The culture supernatant option further simplifies administration by eliminating the need for live microorganisms while preserving immunomodulatory benefits.
3Reliability
If culture supernatant from Prevotella histicola is used, then live microorganisms are eliminated, but the preparation still maintains anti-inflammatory activity
Solution Approach 1:
The patent extracts the active immunomodulatory components from live P. histicola microorganisms by using their culture supernatant. This extraction process separates the beneficial metabolic products, enzymes, and signaling molecules from the living cells themselves. The culture supernatant contains the essential anti-inflammatory substances produced by P. histicola during growth, eliminating the need to administer live microorganisms while preserving therapeutic efficacy.
Data Source
AI summary
This document provides methods and materials related to Prevotella histicola preparations. For example, Prevotella histicola preparations in the form of an oral medicament or dietary supplement (e.g., a pill, tablet, capsule) are provided. In addition, methods and materials for using a Prevotella histicola preparation provided herein as an anti-inflammatory agent are provided.